Merck scraps disappointing experimental cholesterol drug
TRENTON, N.J. (AP) — Merck has decided to abandon efforts to market a closely watched experimental cholesterol medicine after mediocre test results. Merck’s decision Wednesday to not seek regulatory approval after years of...
Read More

